Analytical Data
-
Gene name
LRRC17
- Application
-
Alternative Names
(p37NB)
-
Species
Human
-
Source
E. coli
-
Tag
N- His-KSI
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8N6Y2
-
Expression Region
19-249aa
-
Molecular Weight
42.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LRRC17, or Leucine-Rich Repeat Containing 17, is a protein that has garnered attention due to its potential roles in various biological processes, including cell signaling and immune response. Recent studies have suggested that LRRC17 may be involved in the regulation of neuronal function and may play a significant role in the development and maintenance of the nervous system. Its expression has been noted in various tissues, with particular enrichment in the brain, indicating a possible function in neural pathways. The investigation of LRRC17 recombinant protein is critical to understanding its structure-function relationship, which could reveal insights into its mechanism of action. Additionally, elucidating the role of LRRC17 in pathological states like neurodegenerative diseases may open avenues for therapeutic interventions. The generation of LRRC17 recombinant protein enables researchers to study its interactions with other biomolecules and unveils its potential as a biomarker. Therefore, the study of LRRC17 recombinant protein is not only relevant for basic biological research but also for the development of innovative strategies in medicine.
